Glucarpidase for the management of elevated methotrexate levels in patients with impaired renal function-Reference-Cited by-同舟云学术

Glucarpidase for the management of elevated methotrexate levels in patients with impaired renal function

Published:2014-05-15 Issue:10 Volume:71 Page:793-798
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Fermiano Mariana¹,Bergsbaken Jason²,Kolesar Jill M.¹

Affiliation:

1. State University of Campinas, Sao Paulo, Brazil.

2. University of Wisconsin (UW) Hospital and Clinics, Madison.

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/71/10/793/28372605/ajhp0793.pdf

Reference19 articles.

1. Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia;Csordas;Anticancer Drugs,2013

2. Glucarpidase to combat toxic levels of methotrexate in patients;Green;Ther Clin Risk Manag,2012

3. LaCasce AS, for UpToDate, Inc. Therapeutic use and toxicity of high-dose methotrexate. www.uptodate.com/contents/therapeutic-use-and-toxicity-of-high-dose-methotrexate (accessed 2014 Feb 12).

4. Glucarpidase (carboxypeptidase g2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy;Schwartz;Oncologist,2007

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating methotrexate toxicity: Examining the therapeutic roles of folinic acid and glucarpidase;British Journal of Clinical Pharmacology;2024-06-18

2. Applying real-world data from expanded-access (“compassionate use”) patients to drug development;Journal of Clinical and Translational Science;2023

3. Life-threatening complications after high-dose methotrexate and the benefits of glucarpidase as salvage therapy: a cohort study of 468 patients;Leukemia & Lymphoma;2020-11-12

4. The link between kidney disease and cancer: complications and treatment;The Lancet;2020-07

Length of stay, mortality, and readmissions among Medicare cancer patients treated with glucarpidase and conventional care: a retrospective study

;ClinicoEconomics and Outcomes Research;2019-02